Home › NDC Lookup › RxCUI directory › RxCUI 1085736

Triamcinolone acetonide 0.147 MG/ML Topical Spray — RxCUI 1085736

Name: Triamcinolone acetonide 0.147 MG/ML Topical Spray (RxCUI 1085736)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1085736 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1085736

Official nameTriamcinolone acetonide 0.147 MG/ML Topical Spray

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known astriamcinolone acetonide 0.147 MG/GM Topical Spray

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)301 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
I have diabetes. Should I be worried about using triamcinolone?

📖 Read our full Triamcinolone guide →

🕸️ Concept Web — How Triamcinolone acetonide 0.147 MG/ML Topical Spra... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Triamcinolone acetonide 0.147 MG/ML Topical Spray RxCUI 1085736 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Triamcinolone 10759 IN
- Triamcinolone acetonide 10761 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kenalog 202877 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Triamcinolone Topical Spray 377376 SCDF
- Triamcinolone acetonide Topical Spray 2648767 SCDFP
- Triamcinolone Topical Product 1158231 SCDG
- Triamcinolone acetonide Topical Product 2661113 SCDGP
- Triamcinolone Topical Spray [Kenalog] 93044 SBDF
- Triamcinolone acetonide Topical Spray [Kenalog] 2658365 SBDFP
- Kenalog Topical Product 1170044 SBDG
- Topical Spray 346165 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Triamcinolone acetonide 0.147 MG/ML 1085735 SCDC
- Triamcinolone acetonide 0.147 MG/ML Topical Spray [Kenalog] 1085738 SBD
- Triamcinolone acetonide 0.147 MG/ML [Kenalog] 1085737 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Triamcinolone acetonide 0.147 MG/ML SCDC · 1085735
Triamcinolone Topical Spray SCDF · 377376
Triamcinolone acetonide Topical Spray SCDFP · 2648767
Triamcinolone Topical Product SCDG · 1158231
Triamcinolone acetonide Topical Product SCDGP · 2661113

Brand-Name Concepts

Triamcinolone acetonide 0.147 MG/ML Topical Spray [Kenalog] SBD · 1085738
Triamcinolone acetonide 0.147 MG/ML [Kenalog] SBDC · 1085737
Triamcinolone Topical Spray [Kenalog] SBDF · 93044
Triamcinolone acetonide Topical Spray [Kenalog] SBDFP · 2658365
Kenalog Topical Product SBDG · 1170044
Kenalog BN · 202877

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1085736 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
45802-0045-01	63 g in 1 CAN (45802-045-01)	Triamcinolone Acetonide	Padagis Israel Pharmaceuticals Ltd	2015-04-17
45802-0045-02	100 g in 1 CAN (45802-045-02)	Triamcinolone Acetonide	Padagis Israel Pharmaceuticals Ltd	2015-04-20

Observed labelers: Padagis Israel Pharmaceuticals Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per gm · median

$2.7778

Range $2.3809–$3.1748 · middle 50% $2.5793–$2.9763 · 2 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.